Nicole S. Gierc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nicole S. Gierc has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Brad H. Nelson
Deeley Research Centre, British Columbia Cancer - Victoria, University of British Columbia, Vancouver BC, Canada
55 shared publications Christian Steidl
55 shared publicationsCéline M. Laumont
55 shared publicationsElizabeth A. Chavez
55 shared publicationsJohn R. Webb
55 shared publicationsJulian Smazynski
55 shared publications
Latest Publications
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Table S1 presents relevant information pertaining to patients included in this study.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Table S1 presents relevant information pertaining to patients included in this study.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Table S8 presents results of the multivariate analysis on disease-specific survival on cohort II.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Table S8 presents results of the multivariate analysis on disease-specific survival on cohort II.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Table S3 presents the list of differentially expressed genes identified between triple-positive and triple-negative CD8+ TILs and between triple-positive and other CD8+ TILs.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Table S3 presents the list of differentially expressed genes identified between triple-positive and triple-negative CD8+ TILs and between triple-positive and other CD8+ TILs.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S17 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Figure S17 shows the correlation between relevant triple-positive subsets as assessed by immunofluorescence, flow cytometry and single-cell sequencing.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S17 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Figure S17 shows the correlation between relevant triple-positive subsets as assessed by immunofluorescence, flow cytometry and single-cell sequencing.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Table S6 presents relevant information pertaining to the antibodies used in the 5-color immunofluorescence panel.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Table S6 presents relevant information pertaining to the antibodies used in the 5-color immunofluorescence panel.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Figure S10 shows the marker genes characteristics of T-cell clusters identified by clustering of single-cell gene expression data from TILs.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Figure S10 shows the marker genes characteristics of T-cell clusters identified by clustering of single-cell gene expression data from TILs.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S13 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Figure S13 shows the differential gene expression and TCR repertoire analysis across all subsets of CD8+ TIL isolated from primary HGSC tumor samples.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S13 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Figure S13 shows the differential gene expression and TCR repertoire analysis across all subsets of CD8+ TIL isolated from primary HGSC tumor samples.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Figure S6 shows the comparative analyses of surface biomarker and gene expression of CD103+/- and CD39+/- subpopulations between CD8+ and CD4+ TILs.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Figure S6 shows the comparative analyses of surface biomarker and gene expression of CD103+/- and CD39+/- subpopulations between CD8+ and CD4+ TILs.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S15 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Figure S15 shows the differential gene expression and TCR repertoire analysis across all subsets of Tregs isolated from primary HGSC tumor samples.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S15 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Supplementary Figure S15 shows the differential gene expression and TCR repertoire analysis across all subsets of Tregs isolated from primary HGSC tumor samples.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
List of Supplementary Figures and Tables, Supplementary Methods, and Supplementary References
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
List of Supplementary Figures and Tables, Supplementary Methods, and Supplementary References